arrow
M

Mark A. Jenkins

Melbourne Health
H指数:99
被引数:3.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Genomic characterization of colorectal tumors: insights into significantly mutated genes, pathways, and survival outcomes

结直肠癌肿瘤的基因组特征:对显著突变基因、通路和生存结局的见解

2025-12-180
OAAI
The germline POLD1 c.1420 C > A (p.Leu474Ile) variant segregates with endometrial cancer, colorectal cancer and colonic polyps demonstrating hypermutation and defective POLD1 mutational signatures

生殖系POLD1 c.1420 C > A (p.Leu474Ile)变异与子宫内膜癌、结直肠癌和结肠息肉共存,表现出超突变和POLD1突变谱异常的特征。

2025-11-100
PRE
Cancer risks for MSH6 pathogenic variant carriers

MSH6致病性变异携带者的癌症风险

2025-11-060
PRE
Age-specific trends in colorectal, appendiceal, and anal tumour incidence by histological subtype in Australia from 1990 to 2020: a population-based time-series analysis

1990年至2020年澳大利亚按组织学亚型划分的结直肠、阑尾和肛管肿瘤年龄特异性发病率趋势:一项基于人群的时间序列分析

2025-10-300
OAAI
Multiple polygenic score approach in colorectal cancer risk prediction

结直肠癌风险预测中的多基因评分方法

2025-10-300
OA
Utility of quantitative pathologic analysis of pT1 colorectal carcinomas to improve prediction of lymph node metastasis

定量病理分析对pT1结直肠癌预测淋巴结转移的应用价值

2025-10-080
PRE
Intratumoural pks+ Escherichia coli is associated with risk of metachronous colorectal cancer and adenoma development in people with Lynch syndrome

肿瘤内的pks+大肠杆菌与林奇综合征患者发生异时性结直肠癌和腺瘤发展的风险相关

2025-04-010
OAAI
Menopausal hormone therapy: assessing associations with breast and colorectal cancers by familial risk

更年期激素治疗: 通过家族风险评估与乳腺癌和结直肠癌的关联

2024-12-030
OAAI
Folate intake and colorectal cancer risk according to genetic subtypes defined by targeted tumor sequencing

根据靶向肿瘤测序定义的基因亚型,叶酸摄入量和结直肠癌风险

2024-09-010
OAAI
Genome-wide association studies and Mendelian randomization analyses provide insights into the causes of early-onset colorectal cancer
2024-06-018
OAAI
Two genome-wide interaction loci modify the association of nonsteroidal anti-inflammatory drugs with colorectal cancer

两个全基因组相互作用位点改变非甾体类抗炎药与结直肠癌的关系

2024-05-311
OAAI